The pharmaceutical industry is rapidly evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as example of this trend. To address this demand, US-based manufacturing services are gaining traction. These organizations offer a wide-ranging suite of services, from res